LENSAR to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 27, 2025
LENSAR (Nasdaq: LNSR), a global medical technology company specializing in robotic laser solutions for cataract treatment, has announced its schedule for releasing fourth quarter and full year 2024 financial results. The results will be released before market open on Thursday, February 27, 2025.
The company's management will host a conference call and webcast at 8:30 am ET on the same day to discuss financial results and recent corporate highlights. Participants must register in advance to join the telephone conference. A live webcast will be available in the Investor Relations section of LENSAR's website, with replay access available until March 20, 2025.
LENSAR (Nasdaq: LNSR), un'azienda globale di tecnologia medica specializzata in soluzioni laser robotiche per il trattamento della cataratta, ha annunciato il programma per la pubblicazione dei risultati finanziari del quarto trimestre e dell'intero anno 2024. I risultati saranno pubblicati prima dell'apertura del mercato giovedì 27 febbraio 2025.
La direzione dell'azienda ospiterà una conferenza telefonica e un webcast alle 8:30 ET dello stesso giorno per discutere i risultati finanziari e i recenti punti salienti aziendali. I partecipanti devono registrarsi in anticipo per partecipare alla conferenza telefonica. Un webcast in diretta sarà disponibile nella sezione Relazioni con gli Investitori del sito web di LENSAR, con accesso alla registrazione disponibile fino al 20 marzo 2025.
LENSAR (Nasdaq: LNSR), una empresa global de tecnología médica especializada en soluciones láser robóticas para el tratamiento de cataratas, ha anunciado su programa para publicar los resultados financieros del cuarto trimestre y del año completo 2024. Los resultados se publicarán antes de la apertura del mercado el jueves 27 de febrero de 2025.
La dirección de la empresa llevará a cabo una conferencia telefónica y un webcast a las 8:30 am ET el mismo día para discutir los resultados financieros y los recientes aspectos destacados de la empresa. Los participantes deben registrarse con anticipación para unirse a la conferencia telefónica. Un webcast en vivo estará disponible en la sección de Relaciones con Inversores del sitio web de LENSAR, con acceso a la repetición disponible hasta el 20 de marzo de 2025.
LENSAR (Nasdaq: LNSR)는 백내장 치료를 위한 로봇 레이저 솔루션을 전문으로 하는 글로벌 의료 기술 회사로, 2024년 4분기 및 전체 연도 재무 결과 발표 일정을 발표했습니다. 결과는 2025년 2월 27일 목요일 시장 개장 전에 발표될 예정입니다.
회사의 경영진은 같은 날 오전 8시 30분 ET에 재무 결과 및 최근 기업 하이라이트에 대해 논의하기 위해 전화 회의 및 웹캐스트를 주최합니다. 참가자는 전화 회의에 참여하기 위해 사전 등록해야 합니다. LENSAR 웹사이트의 투자자 관계 섹션에서 생중계 웹캐스트를 이용할 수 있으며, 2025년 3월 20일까지 재생 액세스가 가능합니다.
LENSAR (Nasdaq: LNSR), une entreprise mondiale de technologie médicale spécialisée dans les solutions laser robotiques pour le traitement de la cataracte, a annoncé son calendrier pour la publication des résultats financiers du quatrième trimestre et de l'année 2024. Les résultats seront publiés avant l'ouverture du marché le jeudi 27 février 2025.
La direction de l'entreprise animera une conférence téléphonique et un webcast à 8h30 ET le même jour pour discuter des résultats financiers et des points saillants récents de l'entreprise. Les participants doivent s'inscrire à l'avance pour rejoindre la conférence téléphonique. Un webcast en direct sera disponible dans la section Relations Investisseurs du site Web de LENSAR, avec un accès au replay disponible jusqu'au 20 mars 2025.
LENSAR (Nasdaq: LNSR), ein globales Medizintechnikunternehmen, das auf robotergestützte Laserlösungen zur Behandlung von Katarakten spezialisiert ist, hat seinen Zeitplan für die Veröffentlichung der Finanzberichte für das vierte Quartal und das gesamte Jahr 2024 bekannt gegeben. Die Ergebnisse werden vor Markteröffnung am Donnerstag, den 27. Februar 2025, veröffentlicht.
Das Management des Unternehmens wird am selben Tag um 8:30 Uhr ET eine Telefonkonferenz und einen Webcast abhalten, um die finanziellen Ergebnisse und die jüngsten Unternehmenshighlights zu diskutieren. Teilnehmer müssen sich im Voraus registrieren, um an der Telefonkonferenz teilzunehmen. Ein Live-Webcast wird im Bereich Investor Relations auf der Website von LENSAR verfügbar sein, mit Zugriff auf die Wiederholung bis zum 20. März 2025.
- None.
- None.
ORLANDO, Fla., Feb. 19, 2025 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today announced that the Company’s fourth quarter and full year 2024 financial results will be released before market open on Thursday, February 27, 2025. LENSAR’s management will host a conference call and webcast at 8:30 am ET on Thursday, February 27, 2025 to discuss the financial results and recent corporate highlights.
To participate by telephone, please use this registration link. All participants must use the link to complete the online registration process in advance of the conference call. The live webcast can be accessed under “Events & Presentations” in the Investor Relations section of the company’s website at https://ir.lensar.com. The call and webcast replay will be available until March 20, 2025.
About LENSAR
LENSAR is a commercial-stage medical device company focused on designing, developing, and marketing advanced systems for the treatment of cataracts and the management of astigmatism as an integral aspect of the procedure. LENSAR has developed its ALLY Robotic Cataract Laser System™ as a compact, highly ergonomic system utilizing an extremely fast dual-modality laser and integrating AI into proprietary imaging and software. ALLY is designed to transform premium cataract surgery by utilizing LENSAR’s advanced robotic technologies with the ability to perform the entire procedure in a sterile operating room or in-office surgical suite, delivering operational efficiencies and reduced overhead. ALLY includes LENSAR’s proprietary Streamline® software technology, designed to guide surgeons to achieve better outcomes.
| Contacts: | Lee Roth / Cameron Radinovic |
| Thomas R. Staab, II, CFO | Burns McClellan for LENSAR |
| ir.contact@lensar.com | lroth@burnsmc.com / cradinovic@burnsmc.com |
FAQ
When will LENSAR (LNSR) release its Q4 and full year 2024 earnings?
What time is LENSAR's (LNSR) Q4 2024 earnings call?
How long will LENSAR's (LNSR) Q4 2024 earnings call replay be available?
Where can I access LENSAR's (LNSR) Q4 2024 earnings webcast?
